Federal Review of Research Grants Sparks Hope and Skepticism

The Biden administration has announced a renewed effort to review thousands of science and medical research grant applications that were previously stalled, largely due to their focus on diversity, equity, and inclusion. This development, reported on March 15, 2024, has generated a cautious sense of optimism among researchers and institutions, particularly at the University of Washington, which received $572 million from the National Institutes of Health (NIH) in 2024.

Resuming Stalled Applications

The review affects numerous applications held up by the NIH and the National Science Foundation (NSF), which could lead to significant advancements in areas such as HIV prevention and Alzheimer’s disease. Washington’s Attorney General, Nick Brown, has joined 16 other state attorneys general in a lawsuit against the federal government, highlighting the adverse effects of the previous administration’s decisions on research funding.

In the wake of the administration’s recent agreement, NIH has already acted on hundreds of applications, approving 499 as part of an ongoing effort to clear the backlog. Despite this progress, skepticism remains rooted in historical actions taken by the previous administration.

Historical Context and Ongoing Concerns

During his first term, former President Donald Trump attempted to cut $6.1 billion from NIH research funding, which included crucial allocations for cancer research. Bipartisan efforts in Congress successfully thwarted these attempts, preserving vital funding for medical advancements.

Throughout 2025, Trump sought to exert greater control over higher education institutions, introducing a pause on federal grant applications in January and subsequently cutting research funding, notably for cancer treatments. These moves prompted a series of lawsuits from affected universities, including Cornell University, Columbia University, Brown University, and his alma mater, the University of Pennsylvania, which faced funding threats in exchange for compliance with administration policies on civil rights and diversity in hiring and athletics.

The latest agreement with state attorneys general does not compel the NIH to allocate funds to the stalled applications; it merely requires consideration of them. While the movement towards reviewing these applications is encouraging, it took nearly a year of advocacy and legal action to reach this point.

As the nation looks to regain its footing in the realm of scientific research and technological innovation, the journey ahead remains fraught with challenges. The emphasis on diversity, equity, and inclusion should not be a barrier to advancement but rather a pathway to broader perspectives in research that can benefit all communities.